Investment Q&A

Q: Hi 5i,
Any thoughts on how the revisions to the North America Free Trade Agreement may affect Magna International?

Q: Ever since Intrinsyc released its lackluster Q2 report (but with a positive outlook) insider buyer from the Company's CEO and a director has increased rather significantly. Is this a reliable indicator of what is to come in future results?

Q: Hello, ABT is down by more than 5% this morning. Is this because of the latest financial results? Is there something wrong with these results? On another subject, I know you like MX, is the company's debt acceptable in your view? Regards, Gervais

Q: Kindly critique the ABT results released last night after closing. I'm interested in particular its forward prospect. Thanks.

Q: Are you still comfortable here? Would PHO still be a top pick today?

Q: Can you please provide comment after PHO's conference call? Hopefully management discusses the one time charges that dragged down earnings. Is the story still the same going forward?

Q: What are your thoughts/valuation on VNR in the 5i income portfolio?
Based on the entry price, it looks like you bought around mid 2014 and had a nice 40% gain, inline with the other utilities. But now VNR never gets a mention for utilities to own, and the recommendation is always between FTS, AQN, BEP.UN, or NPI.
I'm retired, living on dividend income and interested in being more defensive in my portfolio and increasing my position in utilities.

Q: Regarding the " legal reserves " question on Crius Energy. I wrote Investor Relations and asked them. This is the reply I got ........
Hello Garth,

The legal reserve charge is related to various claims and proceedings that Crius Energy is a party to, arising in the normal course of business, including several ongoing litigation and regulatory matters relating to certain sales and marketing practices. The company is significantly closer to resolution of these pending claims and has entered into an agreement in principle to settle these matters.

I hope you find this helpful,
Kelly.

Q: Hi there, just looking for further clarification on PLI, have you assessed the risks in Prometic not receiving approval for the Plasminogen BLA from the FDA? Could it be possible that PLI raised further funds very quickly, at a substantial discount, at $1.70, trading well over $2 at that time, suspecting they will not be approved?
"The Corporation is responding diligently to all FDA requests in relation to the BLA review. The Corporation will provide further updates on the expected timeline of regulatory approval as soon as available"
Could it be possible that PLI is suspecting the FDA is looking for further clinical data for approval, which could take an additional 12 to 18 months for final approval? Have you assessed these types of risks in your modelling for the Growth Portfolio holding? Where do you see the stock price trading at, if the above scenario does occur?
Hope I am wrong above!
Thanks!

Q: Can you please comment on PHO results. Thanks

Q: Hi 5i: I am down about 20% in CLS. Has anything fundamental changed in the company? I note that management prediction for the next quarter was reduced. I am considering selling CLS and buying Shopify instead. What would you think of such a move?

Q: While I don't own GUD yet, I keep seeing it reviewed positively and therefore read the FP article you linked:
- "Laurentian Bank Securities analyst sees revenue rising to $6.9 million this year and $52.3 million in 2018 as more drugs work their way through approvals..."

Do you agree with the assessment of projected 2018 revenues of 52.3 million?
If so, what would the implied price of GUD be the end of 2018 based on revenues of 52.3 million?

Q: I don't own PEO however, I'm interested in your positive comments as to its financial condition. Firstly, PEO has about 80% of its assets in Goodwill & Intangibles. Its' NET asset value is really only equal to its debt which would indicate a NAV or Book of approx .75c. Maybe I'm too old or just too conservative. Your comments. Thank you.

Q: things seem to aligning for TV in terms of increase demand for zinc but not enough supply. Bought in based on the addition to the growth portfolio. As this is a cyclical stock do these cycle last for years or should one be planning to exit once a meaningful gain is realized?

Q: David Burroughs just recommended selling due to problems with Samsung - do you concur ?

Q: Is this a good entry point? TX

Q: first valiant, then crh, now pli not doing so well in this sector..
is it time to unload my prometic?

Q: Hi team, For my TFSA would you add to a small position in ECN or start a new position in GSY? Thanks.

Q: Stock was down early this morning but I am glad to see it has recovered.
Any new thoughts given the quarterly report.
Thanks
John

Q: Do you have a feel for what the shares would appreciate if and when the bla is approved for plasminogen.
I hope this is a reasonable question.
Thanks Chester